why choose us

Clinical Trials Search

Showing 15,100 of 132,656 result(s)
Application of Enteral Nutrition Program in Patients With Intra-abdominal Hypertension Oriented by Intra-abdominal Pressure

Status: Completed

Condition: Intra-Abdominal Hypertension

Interventions: Interventional

Date: 2023-02-08

Therapeutic Study of Prostatitis With Elevated PSA

Status: Active, not recruiting

Condition: Prostatitis
PSA

Interventions: Interventional

Date: 2023-02-08

Beyond COVID-19: Supporting Resilience With a Trauma-informed Music Composition Program

Status: Completed

Condition: Problems Related to Life-Management Difficulty

Interventions: Interventional

Date: 2023-02-08

Convolutional Neural Network Model to Detect COVID-19 Infection

Status: Completed

Condition: COVID-19
COVID-19 Pneumonia

Interventions: Other: Categorization of chest xrays images
Use of Convolutional Neural Network Model to categorize chest xrays images in each group.

Date: 2023-02-08

Hemostatic Profile of Post COVID-19/Long COVID-19 Patients

Status: Completed

Condition: COVID-19
Post-acute COVID-19 Syndrome

Interventions: Diagnostic Test: ClotPro assessment
Point-of-care viscoelastic assessment of the coagulation profile (extrinsic pathway, intrinsic pathway, fibri

Date: 2023-02-08

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

Status: Completed

Condition: Acute Myeloid Leukemia (AML)

Interventions: Dose level (-1) 80mg, (1) 120mg, (2) 120mg

Date: 2023-02-08

Metoclopramide in Upper Gastrointestinal Bleed

Status: Completed

Condition: Upper GI Bleeding

Interventions: IV Metoclopramide

Date: 2023-02-08

An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases

Status: Completed

Condition: Lupus Nephritis

Interventions: Administered by subcutaneous injection every 4 weeks

Date: 2023-02-08

A Study of TAS3351 in NSCLC Patients With EGFRmt

Status: Completed

Condition: Non-Small Cell Lung Cancer

Interventions: TAS3351 will be administered orally

Date: 2023-02-08

Dinner Time for Obesity and Prediabetes

Status: Completed

Condition: PreDiabetes

Interventions: Dinner before DLMO

Date: 2023-02-08